The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.
Global Antidiabetics market is projected to reach US$ 85960 million in 2029, increasing from US$ 58180 million in 2022, with the CAGR of 5.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antidiabetics market research.
The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share.
Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antidiabetics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Sanofi-Aventis
- Takeda Pharmaceuticals
- Eli Lilly
- Oramed Pharmaceuticals
- Boehringer Ingelheim
- Merck & Co. Inc.
- Novo Nordisk
- Bristol-Myers Squibb
- Halozyme Therapeutics
- Pfizer
Segment by Type
- Type 1 Diabetes
- Type 2 Diabetes
- Other
Segment by Application
- Hospital Use
- Clinic Use
- Household
- Other
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
The Antidiabetics report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1.1 Product Overview and Scope of Antidiabetics
1.2 Antidiabetics Segment by Type
1.2.1 Global Antidiabetics Market Value Comparison by Type (2023-2029)
1.2.2 Type 1 Diabetes
1.2.3 Type 2 Diabetes
1.2.4 Other
1.3 Antidiabetics Segment by Application
1.3.1 Global Antidiabetics Market Value by Application: (2023-2029)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Global Antidiabetics Market Size Estimates and Forecasts
1.4.1 Global Antidiabetics Revenue 2018-2029
1.4.2 Global Antidiabetics Sales 2018-2029
1.4.3 Global Antidiabetics Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Antidiabetics Market Competition by Manufacturers
2.1 Global Antidiabetics Sales Market Share by Manufacturers (2018-2023)
2.2 Global Antidiabetics Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Antidiabetics Average Price by Manufacturers (2018-2023)
2.4 Global Antidiabetics Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Antidiabetics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antidiabetics, Product Type & Application
2.7 Antidiabetics Market Competitive Situation and Trends
2.7.1 Antidiabetics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antidiabetics Players Market Share by Revenue
2.7.3 Global Antidiabetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antidiabetics Retrospective Market Scenario by Region
3.1 Global Antidiabetics Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Antidiabetics Global Antidiabetics Sales by Region: 2018-2029
3.2.1 Global Antidiabetics Sales by Region: 2018-2023
3.2.2 Global Antidiabetics Sales by Region: 2024-2029
3.3 Global Antidiabetics Global Antidiabetics Revenue by Region: 2018-2029
3.3.1 Global Antidiabetics Revenue by Region: 2018-2023
3.3.2 Global Antidiabetics Revenue by Region: 2024-2029
3.4 North America Antidiabetics Market Facts & Figures by Country
3.4.1 North America Antidiabetics Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Antidiabetics Sales by Country (2018-2029)
3.4.3 North America Antidiabetics Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antidiabetics Market Facts & Figures by Country
3.5.1 Europe Antidiabetics Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Antidiabetics Sales by Country (2018-2029)
3.5.3 Europe Antidiabetics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antidiabetics Market Facts & Figures by Country
3.6.1 Asia Pacific Antidiabetics Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Antidiabetics Sales by Country (2018-2029)
3.6.3 Asia Pacific Antidiabetics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antidiabetics Market Facts & Figures by Country
3.7.1 Latin America Antidiabetics Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Antidiabetics Sales by Country (2018-2029)
3.7.3 Latin America Antidiabetics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antidiabetics Market Facts & Figures by Country
3.8.1 Middle East and Africa Antidiabetics Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Antidiabetics Sales by Country (2018-2029)
3.8.3 Middle East and Africa Antidiabetics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antidiabetics Sales by Type (2018-2029)
4.1.1 Global Antidiabetics Sales by Type (2018-2023)
4.1.2 Global Antidiabetics Sales by Type (2024-2029)
4.1.3 Global Antidiabetics Sales Market Share by Type (2018-2029)
4.2 Global Antidiabetics Revenue by Type (2018-2029)
4.2.1 Global Antidiabetics Revenue by Type (2018-2023)
4.2.2 Global Antidiabetics Revenue by Type (2024-2029)
4.2.3 Global Antidiabetics Revenue Market Share by Type (2018-2029)
4.3 Global Antidiabetics Price by Type (2018-2029)
5 Segment by Application
5.1 Global Antidiabetics Sales by Application (2018-2029)
5.1.1 Global Antidiabetics Sales by Application (2018-2023)
5.1.2 Global Antidiabetics Sales by Application (2024-2029)
5.1.3 Global Antidiabetics Sales Market Share by Application (2018-2029)
5.2 Global Antidiabetics Revenue by Application (2018-2029)
5.2.1 Global Antidiabetics Revenue by Application (2018-2023)
5.2.2 Global Antidiabetics Revenue by Application (2024-2029)
5.2.3 Global Antidiabetics Revenue Market Share by Application (2018-2029)
5.3 Global Antidiabetics Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Corporation Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Antidiabetics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi-Aventis Antidiabetics Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 Takeda Pharmaceuticals
6.2.1 Takeda Pharmaceuticals Corporation Information
6.2.2 Takeda Pharmaceuticals Description and Business Overview
6.2.3 Takeda Pharmaceuticals Antidiabetics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Takeda Pharmaceuticals Antidiabetics Product Portfolio
6.2.5 Takeda Pharmaceuticals Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Antidiabetics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly Antidiabetics Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Oramed Pharmaceuticals
6.4.1 Oramed Pharmaceuticals Corporation Information
6.4.2 Oramed Pharmaceuticals Description and Business Overview
6.4.3 Oramed Pharmaceuticals Antidiabetics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Oramed Pharmaceuticals Antidiabetics Product Portfolio
6.4.5 Oramed Pharmaceuticals Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Antidiabetics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Boehringer Ingelheim Antidiabetics Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Merck & Co. Inc.
6.6.1 Merck & Co. Inc. Corporation Information
6.6.2 Merck & Co. Inc. Description and Business Overview
6.6.3 Merck & Co. Inc. Antidiabetics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck & Co. Inc. Antidiabetics Product Portfolio
6.6.5 Merck & Co. Inc. Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Antidiabetics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novo Nordisk Antidiabetics Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Antidiabetics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bristol-Myers Squibb Antidiabetics Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Halozyme Therapeutics
6.9.1 Halozyme Therapeutics Corporation Information
6.9.2 Halozyme Therapeutics Description and Business Overview
6.9.3 Halozyme Therapeutics Antidiabetics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Halozyme Therapeutics Antidiabetics Product Portfolio
6.9.5 Halozyme Therapeutics Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Antidiabetics Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pfizer Antidiabetics Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antidiabetics Industry Chain Analysis
7.2 Antidiabetics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antidiabetics Production Mode & Process
7.4 Antidiabetics Sales and Marketing
7.4.1 Antidiabetics Sales Channels
7.4.2 Antidiabetics Distributors
7.5 Antidiabetics Customers
8 Antidiabetics Market Dynamics
8.1 Antidiabetics Industry Trends
8.2 Antidiabetics Market Drivers
8.3 Antidiabetics Market Challenges
8.4 Antidiabetics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
